Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37770979)

  • 1. Therapeutic targeting of the TPX2/TTK network in colorectal cancer.
    Shaath H; Vishnubalaji R; Elango R; Velayutham D; Jithesh PV; Alajez NM
    Cell Commun Signal; 2023 Sep; 21(1):265. PubMed ID: 37770979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CWH43 Is a Novel Tumor Suppressor Gene with Negative Regulation of TTK in Colorectal Cancer.
    Lee CC; Tsai KY; Lee AW; Wei PL; Huang CY; Batzorig U; Chang YJ
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.
    Takahashi Y; Sheridan P; Niida A; Sawada G; Uchi R; Mizuno H; Kurashige J; Sugimachi K; Sasaki S; Shimada Y; Hase K; Kusunoki M; Kudo S; Watanabe M; Yamada K; Sugihara K; Yamamoto H; Suzuki A; Doki Y; Miyano S; Mori M; Mimori K
    Ann Oncol; 2015 May; 26(5):935-942. PubMed ID: 25632068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of tyrosine and threonine protein kinase in carcinogenic process of colorectal cancer and its relationship with prognosis].
    Zhang XL; Han WX; Ma YM; Baohan HW; Zhao XH; Wang HY
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):172-177. PubMed ID: 28316214
    [No Abstract]   [Full Text] [Related]  

  • 5. Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells.
    Kaistha BP; Honstein T; Müller V; Bielak S; Sauer M; Kreider R; Fassan M; Scarpa A; Schmees C; Volkmer H; Gress TM; Buchholz M
    Br J Cancer; 2014 Oct; 111(9):1780-7. PubMed ID: 25137017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
    Sillars-Hardebol AH; Carvalho B; Tijssen M; Beliën JA; de Wit M; Delis-van Diemen PM; Pontén F; van de Wiel MA; Fijneman RJ; Meijer GA
    Gut; 2012 Nov; 61(11):1568-75. PubMed ID: 22207630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular subtyping and functional validation of TTK, TPX2, UBE2C, and LRP8 in sensitivity of TNBC to paclitaxel.
    Elango R; Vishnubalaji R; Shaath H; Alajez NM
    Mol Ther Methods Clin Dev; 2021 Mar; 20():601-614. PubMed ID: 33665229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1.
    Khedkar HN; Wang YC; Yadav VK; Srivastava P; Lawal B; Mokgautsi N; Sumitra MR; Wu ATH; Huang HS
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-485-3p suppresses colorectal cancer via targeting TPX2.
    Taherdangkoo K; Kazemi Nezhad SR; Hajjari MR; Tahmasebi Birgani M
    Bratisl Lek Listy; 2020; 121(4):302-307. PubMed ID: 32356447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer.
    Gomes-Filho SM; Dos Santos EO; Bertoldi ERM; Scalabrini LC; Heidrich V; Dazzani B; Levantini E; Reis EM; Bassères DS
    Cell Oncol (Dordr); 2020 Jun; 43(3):445-460. PubMed ID: 32193808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer.
    Miao Y; Konno Y; Wang B; Zhu L; Zhai T; Ihira K; Kobayashi N; Watari H; Jin X; Yue J; Dong P; Fang M
    J Transl Med; 2023 Feb; 21(1):151. PubMed ID: 36829176
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Yang Q; Qi M; Chen Y; Tian S; Liao F; Dong W
    DNA Cell Biol; 2021 Jul; 40(7):921-935. PubMed ID: 34042518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients.
    Kahl I; Mense J; Finke C; Boller AL; Lorber C; Győrffy B; Greve B; Götte M; Espinoza-Sánchez NA
    J Cell Biochem; 2022 Mar; 123(3):581-600. PubMed ID: 35014077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitotic checkpoint kinase Mps1/TTK predicts prognosis of colon cancer patients and regulates tumor proliferation and differentiation via PKCα/ERK1/2 and PI3K/Akt pathway.
    Zhang L; Jiang B; Zhu N; Tao M; Jun Y; Chen X; Wang Q; Luo C
    Med Oncol; 2019 Nov; 37(1):5. PubMed ID: 31720873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer.
    Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X
    Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
    Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ashwagandha derived withanone targets TPX2-Aurora A complex: computational and experimental evidence to its anticancer activity.
    Grover A; Singh R; Shandilya A; Priyandoko D; Agrawal V; Bisaria VS; Wadhwa R; Kaul SC; Sundar D
    PLoS One; 2012; 7(1):e30890. PubMed ID: 22303466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics and experimental validation of an AURKA/TPX2 axis as a potential target in esophageal squamous cell carcinoma.
    Du R; Li K; Zhou Z; Huang Y; Guo K; Zhang H; Chen Z; Zhao X; Han L; Bian H
    Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37083097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TPX2 promotes cell proliferation and migration via PLK1 in OC.
    Ma S; Rong X; Gao F; Yang Y; Wei L
    Cancer Biomark; 2018; 22(3):443-451. PubMed ID: 29865033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.